Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-Agent Selinexor Versus Physician's Choice in Previously Treated Myelofibrosis: Results From the Phase 2 XPORT-035 Study.

EJHaem·2026
Same author

KCa3.1 mediates radioresistance of silver nanoparticles in human glioblastoma cells.

Pflugers Archiv : European journal of physiology·2026
Same author

Neuroinflammatory changes in acute myeloid leukemia: Evidence for blood-brain barrier disruption and glial activation.

HemaSphere·2026
Same author

Early Ibrutinib Dose Modifications in CLL: A Post Hoc Analysis of the Real-World EVIdeNCE Study.

Cancers·2026
Same author

Clinical Outcomes of Ruxolitinib Treatment in Patients With IPSS Intermediate-1-Risk Myelofibrosis: Interim Analysis From an Italian, Prospective Study (ROMEI).

Hematological oncology·2026
Same author

Incidence of severe COVID-19 in patients with chronic lymphocytic leukaemia or indolent B-cell non-Hodgkin lymphoma who received vaccination and pre-exposure prophylaxis with tixagevimab and cilgavimab in Italy: An observational study by the GIMEMA working party on chronic lymphoproliferative disorders and by the Fondazione Italiana Linfomi.

British journal of haematology·2026
Same journal

When Platelet Stimulation Becomes Marrow Stress: Rethinking Thrombopoietin Receptor Agonist Intensification in Pediatric Immune Thrombocytopenia.

Pediatric reports·2026
Same journal

Effects of White Noise on Academic Skills in Children with ADHD and Specific Learning Disorders: New Perspectives for Personalised Rehabilitation and Educational Intervention.

Pediatric reports·2026
Same journal

Blended and Technology-Enhanced Education in Pediatric Emergency Nursing: A Systematic Review.

Pediatric reports·2026
Same journal

A Century of Post-Traumatic Appendicitis: A Comprehensive Review with an Illustrative Case.

Pediatric reports·2026
Same journal

A Coordinated Adhesion-Molecule Activation Profile in Pediatric Sepsis: A Prospective Cohort Study from Vietnam.

Pediatric reports·2026
Same journal

Efficacy and Safety of Umifenovir (Arbidol) in Children with Influenza-like Illnesses: A Systematic Review and Meta-Analysis.

Pediatric reports·2026
See all related articles

Related Experiment Video

Updated: May 27, 2026

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice
10:02

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice

Published on: January 6, 2023

How does the NPM1 mutant induce leukemia?

Paolo Sportoletti1

  • 1Hematology and Clinical Immunology Section, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy.

Pediatric Reports
|November 5, 2011
PubMed
Summary
This summary is machine-generated.

The NPM1 gene mutation is common in acute myeloid leukemia (AML). Research is ongoing to understand how NPM1 mutations contribute to leukemia development and its potential as a therapeutic target.

Keywords:
NPMlleukemia.

More Related Videos

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
08:00

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model

Published on: October 14, 2016

Assessing Somatic Hypermutation in Ramos B Cells after Overexpression or Knockdown of Specific Genes
08:12

Assessing Somatic Hypermutation in Ramos B Cells after Overexpression or Knockdown of Specific Genes

Published on: November 1, 2011

Related Experiment Videos

Last Updated: May 27, 2026

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice
10:02

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice

Published on: January 6, 2023

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
08:00

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model

Published on: October 14, 2016

Assessing Somatic Hypermutation in Ramos B Cells after Overexpression or Knockdown of Specific Genes
08:12

Assessing Somatic Hypermutation in Ramos B Cells after Overexpression or Knockdown of Specific Genes

Published on: November 1, 2011

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Nuclear protein NPM1 is the most frequently mutated gene in acute myeloid leukemia (AML).
  • NPM1 mutations are implicated in leukemogenesis through oncogenic effects and loss of function.
  • Npm1 loss is linked to tumor development in mice and chromosomal alterations in human myelodysplastic syndrome (MDS).

Purpose of the Study:

  • To review current research on the role of NPM1 in hematological malignancies.
  • To elucidate the mechanisms by which NPM1 mutations induce leukemia.
  • To explore the leukemogenic potential of NPM1 mutants.

Main Methods:

  • Review of relevant scientific literature.
  • Analysis of in vitro studies on NPM1 function.
  • Examination of in vivo studies investigating NPM1's role in leukemia.

Main Results:

  • NPM1 mutations contribute to leukemia via direct oncogenic effects and loss of a functional allele.
  • Cytoplasmic delocalization of NPM1 mutants in leukemic cells disrupts cellular pathways.
  • Studies suggest NPM1 alterations are critical in the development of hematological malignancies.

Conclusions:

  • NPM1 mutations play a significant role in the pathogenesis of AML.
  • Further investigation into NPM1's function and interactions is crucial for understanding leukemia.
  • Targeting NPM1 may offer potential therapeutic strategies for AML and related disorders.